AT-Patch (ATP-C130/ATP-C70) vs uCT 780

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AT-Patch (ATP-C130/ATP-C70)

by ATsens Co.

uCT 780

by United Imaging Healthcare

AI Verdict

These two tools are adjacent rather than direct competitors, despite both leveraging AI in cardiology. The AT-Patch is an ambulatory wearable ECG monitor focused on continuous cardiac monitoring and arrhythmia detection, ideal for long-term electrical activity assessment. In contrast, the uCT 780 is a stationary CT scanner designed for high-resolution anatomical imaging and precision diagnostics, particularly for structural cardiac evaluation.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you require extended, continuous ambulatory ECG monitoring for up to 14 days to detect intermittent arrhythmias or evaluate cardiac activity in a patient's natural environment. Its lightweight, shower-proof design and AI-powered analysis are ideal for comfortable, long-term patient compliance and efficient arrhythmia detection.

View AT-Patch (ATP-C130/ATP-C70) →

Choose uCT 780 if…

Choose uCT 780 if you need high-resolution, low-dose cross-sectional imaging for detailed anatomical assessment, particularly for complex cardiac diagnostics or pre-procedural planning. Its 160-slice capability, rapid rotation, and advanced AI-powered features like CardioXphase provide precise, diagnostic-quality images for intricate structural evaluation.

View uCT 780 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AT-Patch (ATP-C130/ATP-C70)	uCT 780
Deployment	Wearable device for patients; analysis software deployed on-premise at medical institutions.	On-premise
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch (Tool A) prioritizes patient usability with its compact, lightweight, and shower-proof design, offering up to 14 days of continuous monitoring without requiring patient intervention for charging or electrode replacement. The accompanying smartphone app further enhances ease of use for patients to view ECG and record symptoms.

Clinical Value

Tie

Both tools offer significant, FDA-cleared clinical value within their respective domains in cardiology. AT-Patch provides crucial long-term ECG data with AI-powered analysis for enhanced arrhythmia detection, while uCT 780 delivers high-resolution, low-dose CT imaging for detailed anatomical and cardiac diagnostics.

Pricing & Value

Tie

Neither AT-Patch nor uCT 780 publicly discloses pricing information, which is typical for specialized medical devices requiring direct sales or consultation. Without any transparent pricing details, it is impossible to conduct a comparative assessment of their value propositions.

Enterprise Readiness

uCT 780

The uCT 780 (Tool B) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), which are critical assurances for healthcare enterprises handling protected health information. AT-Patch (Tool A) only states HIPAA compliance is 'likely' and does not explicitly mention a BAA, indicating a potential gap in readily available enterprise-level compliance documentation.

Innovation

uCT 780

The uCT 780 (Tool B) demonstrates broader innovation by integrating a 160-slice CT scanner with advanced hardware like the Z-Detector, AI-empowered workflow via the uAI Vision 3D camera, and multiple low-dose and metal artifact correction technologies. While AT-Patch is innovative in wearable design and AI for ECG analysis, Tool B's comprehensive technological advancements across a complex imaging system are more extensive.

Support & Docs

Tie

The provided structured facts and general web searches do not offer sufficient specific details regarding the depth, accessibility, or quality of support and documentation for either AT-Patch or uCT 780. Both companies are expected to provide standard enterprise-level support and documentation to their institutional clients, but no differentiating information is available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AT-Patch (ATP-C130/ATP-C70)	uCT 780
Name	AT-Patch (ATP-C130/ATP-C70)	uCT 780
Company	ATsens Co.	Shanghai United Imaging Healthcare Co.
Description	FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy, a shower-proof design, and integrated AI-powered analysis software for enhanced arrhythmia detection.	A 160-slice CT scanner integrating AI-powered workflows and advanced hardware for high-quality, low-dose imaging, particularly for cardiac and detailed anatomical scans.
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Interventional Radiology, Radiology
Key Features (Cardiac Specific)	Up to 14 days of continuous ECG monitoring (ATP-C130), High-performance sensor chip for accurate ECG signal acquisition, AT-Report software with AI/machine learning algorithms for ECG analysis	0.3s rotation speed and 150ms native temporal resolution, Dynamic pitch technology for seamless coronary and vascular imaging, CardioXphase technology for advanced cardiac diagnostics

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and uCT 780.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and diagnostic focus of the AT-Patch versus the uCT 780?

The AT-Patch is an FDA-cleared wearable ECG monitor designed for up to 14 days of continuous cardiac monitoring, primarily for enhanced arrhythmia detection. In contrast, the uCT 780 is a 160-slice CT scanner focused on high-quality, low-dose imaging, particularly for cardiac and detailed anatomical scans.

How do the AI capabilities of each tool contribute to improved diagnostics or workflow?

The AT-Patch utilizes AI/machine learning algorithms within its AT-Report software for ECG analysis, aiming to enhance arrhythmia detection. The uCT 780 integrates AI-powered workflows through its uAI Vision 3D camera for an efficient and standardized scanning experience, and employs AI for low-dose imaging with KARL 3D denoising.

What are the key differences in patient experience and monitoring/imaging duration between the two devices?

The AT-Patch is a compact, lightweight (13g) wearable device offering up to 14 days of continuous ECG monitoring, featuring a shower-proof design and a smartphone app for live ECG viewing and symptom recording. The uCT 780 is an on-premise CT scanner that provides rapid, detailed anatomical images with a 0.3s rotation speed and 150ms native temporal resolution, representing a snapshot imaging approach.

What specific cardiac conditions or assessments are each tool best suited for?

The AT-Patch is best suited for long-term continuous ECG monitoring to detect arrhythmias and other cardiac events, aiding in the diagnosis of heart conditions for patients with symptoms like palpitations or dizziness. The uCT 780, with features like dynamic pitch technology and CardioXphase, is designed for seamless coronary and vascular imaging and advanced cardiac diagnostics.

What are the data security and compliance assurances for patient data with each tool?

The AT-Patch is likely HIPAA compliant given its FDA clearance and operation within the US healthcare system for patient data, though a Business Associate Agreement (BAA) is not explicitly mentioned in its details. The uCT 780 is explicitly stated to be HIPAA compliant and has a Business Associate Agreement (BAA) confirmed.